BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 9712020)

  • 1. Identification of an additional isoform of STAT5 expressed in immature macrophages.
    Lokuta MA; McDowell MA; Paulnock DM
    J Immunol; 1998 Aug; 161(4):1594-7. PubMed ID: 9712020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiapoptotic activity of Stat5 required during terminal stages of myeloid differentiation.
    Kieslinger M; Woldman I; Moriggl R; Hofmann J; Marine JC; Ihle JN; Beug H; Decker T
    Genes Dev; 2000 Jan; 14(2):232-44. PubMed ID: 10652277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EGF modulates expression of STAT5 in mammary epithelial cells.
    Petersen H; Haldosén LA
    Exp Cell Res; 1998 Sep; 243(2):347-58. PubMed ID: 9743594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulated expression of COOH-terminally truncated Stat5 and loss of IL2-inducible Stat5-dependent gene expression in Sezary Syndrome.
    Mitchell TJ; Whittaker SJ; John S
    Cancer Res; 2003 Dec; 63(24):9048-54. PubMed ID: 14695224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-3 dependent regulation of Bcl-xL gene expression by STAT5 in a bone marrow derived cell line.
    Dumon S; Santos SC; Debierre-Grockiego F; Gouilleux-Gruart V; Cocault L; Boucheron C; Mollat P; Gisselbrecht S; Gouilleux F
    Oncogene; 1999 Jul; 18(29):4191-9. PubMed ID: 10435632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of STAT5 proteins in the regulation of normal hematopoiesis in a cord blood model.
    Baśkiewicz-Masiuk M; Masiuk M; Czajka R; Machaliński B
    Cell Mol Biol Lett; 2003; 8(2):317-31. PubMed ID: 12813566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutively active STAT5A and STAT5B in vitro and in vivo: mutation of STAT5 is not a frequent cause of leukemogenesis.
    Yamada K; Ariyoshi K; Onishi M; Miyajima A; Hayakawa F; Towatari M; Saito H; Oka Y; Asano S; Nosaka T; Kitamura T
    Int J Hematol; 2000 Jan; 71(1):46-54. PubMed ID: 10729993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous, bidirectional inhibitory crosstalk between PPAR and STAT5b.
    Shipley JM; Waxman DJ
    Toxicol Appl Pharmacol; 2004 Sep; 199(3):275-84. PubMed ID: 15364543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPARgamma ligand-dependent induction of STAT1, STAT5A, and STAT5B during adipogenesis.
    Stephens JM; Morrison RF; Wu Z; Farmer SR
    Biochem Biophys Res Commun; 1999 Aug; 262(1):216-22. PubMed ID: 10448095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enforced activation of STAT5A facilitates the generation of embryonic stem-derived hematopoietic stem cells that contribute to hematopoiesis in vivo.
    Schuringa JJ; Wu K; Morrone G; Moore MA
    Stem Cells; 2004; 22(7):1191-204. PubMed ID: 15579639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutive activation of Stat5b contributes to carcinogenesis in vivo.
    Xi S; Zhang Q; Gooding WE; Smithgall TE; Grandis JR
    Cancer Res; 2003 Oct; 63(20):6763-71. PubMed ID: 14583472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of a functionally distinct 80-kDa STAT5 isoform by IL-5 and GM-CSF in human eosinophils and neutrophils.
    Caldenhoven E; van Dijk TB; Raaijmakers JA; Lammers JW; Koenderman L; de Groot RP
    Mol Cell Biol Res Commun; 1999 May; 1(2):95-101. PubMed ID: 10356357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential function of STAT5 isoforms in head and neck cancer growth control.
    Leong PL; Xi S; Drenning SD; Dyer KF; Wentzel AL; Lerner EC; Smithgall TE; Grandis JR
    Oncogene; 2002 Apr; 21(18):2846-53. PubMed ID: 11973644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of signal transducer and activator of transcription 5 is required for progression of autochthonous prostate cancer: evidence from the transgenic adenocarcinoma of the mouse prostate system.
    Kazansky AV; Spencer DM; Greenberg NM
    Cancer Res; 2003 Dec; 63(24):8757-62. PubMed ID: 14695191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential activation of functionally distinct STAT5 proteins by IL-5 and GM-CSF during eosinophil and neutrophil differentiation from human CD34+ hematopoietic stem cells.
    Caldenhoven E; van Dijk TB; Tijmensen A; Raaijmakers JA; Lammers JW; Koenderman L; de Groot RP
    Stem Cells; 1998; 16(6):397-403. PubMed ID: 9831865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the STAT5 proteins in the proliferation and apoptosis of the CML and AML cells.
    Baśkiewicz-Masiuk M; Machaliński B
    Eur J Haematol; 2004 Jun; 72(6):420-9. PubMed ID: 15128421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delineation and mapping of Stat5 isoforms activated by granulocyte colony-stimulating factor in myeloid cells.
    Chakraborty A; Dyer KF; Tweardy DJ
    Blood Cells Mol Dis; 2000 Aug; 26(4):320-30. PubMed ID: 11042034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression and forced activation of stat5 in mammary gland of transgenic mice promotes cellular proliferation, enhances differentiation, and delays postlactational apoptosis.
    Iavnilovitch E; Groner B; Barash I
    Mol Cancer Res; 2002 Nov; 1(1):32-47. PubMed ID: 12496367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunocompromised tumor-bearing mice show a selective loss of STAT5a/b expression in T and B lymphocytes.
    Pericle F; Kirken RA; Bronte V; Sconocchia G; DaSilva L; Segal DM
    J Immunol; 1997 Sep; 159(6):2580-5. PubMed ID: 9300676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonopsonic and opsonic association of Mycobacterium tuberculosis with resident alveolar macrophages is inefficient.
    Stokes RW; Thorson LM; Speert DP
    J Immunol; 1998 Jun; 160(11):5514-21. PubMed ID: 9605155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.